Zydus Lifesciences Limited (BOM:532321)
1,195.05
-4.95 (-0.41%)
At close: Nov 20, 2026
Zydus Lifesciences Market Cap
Zydus Lifesciences has a market cap or net worth of 1.2 trillion as of November 20, 2026. Its market cap has increased by 27.89% in one year.
Market Cap
1.20T
Enterprise Value
1.31T
Revenue
303.78B
Global Rank
n/a
Country Rank
n/a
PE Ratio
28.57
ChartMarket Cap Chart
Since May 15, 2002, Zydus Lifesciences's market cap has increased from 8.20B to 1.20T, an increase of 14,505.12%. That is a compound annual growth rate of 22.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 1.20T | 30.10% |
| Dec 31, 2025 | 920.05B | -5.90% |
| Dec 31, 2024 | 977.76B | 40.16% |
| Dec 29, 2023 | 697.61B | 64.11% |
| Dec 30, 2022 | 425.08B | -14.06% |
| Dec 31, 2021 | 494.62B | 1.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 2.96T |
| Laurus Labs | 1.25T |
| Zydus Lifesciences | 1.20T |
| Cipla | 1.15T |
| Mankind Pharma | 1.10T |
| Aurobindo Pharma | 1.04T |
| Glenmark Pharmaceuticals | 741.62B |
| Alkem Laboratories | 615.52B |